Pd60-04 Defining a Favorable Intermediate-risk Group: Utility of Magnetic Resonance Imaging and Genetic Tests.
Year: 2018
Type: article
Study design: Observational Study
Abstract: PSA level (Hazard ratio [HR: 1.01]), pN1 status (HR: 1.63) and grade group 4-5 (HR: 1.79) were associated with CR.The impact of the first PSA level on the risk of CR differed according to nodal status (p<0.001) but not by grade or stage (all p0.1).An increase in the rate of CR at 10-year was observed for pN0 patients with a first PSA >0.25ng/ml.The 10-year CR-free survival were 85.9 vs 76.1% for a first PSA 0.25 vs >0.25ng/ml (p<0.001).In pN1 the risk of CR increased according to the first PSA without a plateau, with a 10year CR-free survival rate of 59%.CONCLUSIONS: The first PSA level after RP should stratify node-negative men where the optimal definition of meaningful PSA persistence associated with 10-year CR was 0.25 ng/ml.These data should be used to tailor the optimal timely salvage therapy in these men.
Source: The Journal of Urology
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2795904673
